Alzheimer’s disease

Author(s): Burns A, Iliffe S

Abstract

People with mild cognitive impairment are up to 15 times more likely to develop Alzheimer’s disease than those with normal cognition

Memory loss is a presenting symptom in most people who develop Alzheimer’s disease

The cause of Alzheimer’s disease is unknown, but genetic and environmental risk factors have been implicated

Cholinesterase inhibitors are safe and effective and can be prescribed for people in the moderate stages of Alzheimer’s disease

Antipsychotic drugs reduce agitation but are linked with an increased risk of mortality and impair cognition

Evidence is growing that some strategies are successful at preventing Alzheimer’s disease

Similar Articles

Alzheimer's disease and the Amyloid-β Peptide

Author(s): Murphy MP, LeVine H

Adrenergic receptors in aging and Alzheimer's disease: Increased β2-Receptors in prefrontal cortex and hippocampus

Author(s): Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, et al.

Antihypertensive medication use and risk of cognitive impairment: The Honolulu-Asia Aging Study

Author(s): Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, et al.

Antihypertensive medication use and risk of cognitive impairment: The Honolulu-Asia aging study

Author(s): Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, et al.

Epac: Defining a new mechanism for cAMP action

Author(s): Gloerich M, Bos JL

G protein beta gamma subunits

Author(s): Clapham DE, Neer EJ

Recombinant G-protein βγ-subunits activate the muscarinic-gated atrial potassium channel

Author(s): Wickman KD, Iniguez-Lluhl JA, Davenport PA, Taussig R, Krapivinsky GB, et al.

G-protein beta Gamma-subunits activate the cardiac muscarinic K+-channel via phospholipase A2

Author(s): Kim D, Lewis DL, Graziadei L, Neer EJ, Bar-Sagi D, et al.

The expanding roles of Gβγ subunits in G Protein-coupled receptor signaling and drug action

Author(s): Khan SM, Sleno R, Gora S, Zylbergold P, Laverdure JP, et al.

Binding of amyloid β peptide to β2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity

Author(s): Wang D, Govindaiah G, Liu R, De Arcangelis V, Cox CL, et al.

Alzheimer's disease

Author(s): Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, et al.

Brain amyloid-β oligomers in ageing and Alzheimer’s disease

Author(s): Lesne SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, et al.

The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia

Author(s): Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, et al.

Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease

Author(s): Ross JA, McGonigle P1, Van Bockstaele EJ

Statistical significance for genomewide studies

Author(s): Storey JD, Tibshirani R

Mechanisms of phagocytosis in macrophages

Author(s): Aderem A, Underhill DM